Invokana for Cardiovascular Risk Reduction User Reviews
Invokana has no reviews submitted for this condition. Be the first to review this drug.
Learn more about Cardiovascular Risk Reduction
More about Invokana (canagliflozin)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (257)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: SGLT-2 inhibitors
- Breastfeeding
- En español